TipRanks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
QNCX
Quince Therapeutics
RESEARCH TOOLSreports
Want to see QNCX full AI Analyst Report?

Quince Therapeutics (QNCX) Income Statement

1,049 Followers

Quince Therapeutics Income Statement

Last quarter (Q2 2026), Quince Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Quince Therapeutics's net income was $-75.49M. See Quince Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -142.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 50.29M$ 57.28M$ 34.62M$ 52.02M$ 90.32M
Depreciation and Amortization
$ 142.00K$ 186.00K$ 322.00K$ 204.00K$ 344.00K
EBITDA
$ -80.62M$ -35.98M$ -26.82M$ -50.99M$ -89.60M
Operating Income
$ -50.43M$ -57.28M$ -34.62M$ -52.02M$ -90.32M
Other Income/Expenses
$ -30.34M$ 544.00K$ 3.04M$ 71.00K$ 373.00K
Pretax Income
$ -80.77M$ -56.74M$ -31.58M$ -51.94M$ -89.94M
Net Income
$ -83.98M$ -56.83M$ -31.39M$ -51.66M$ -89.94M
Per Share Metrics
Basic EPS
$ -336.00$ -262.00$ -168.00$ -308.00$ -606.00
Diluted EPS
$ -336.00$ -262.00$ -168.00$ -308.00$ -606.00
Weighted Average Shares Outstanding
 250.49K 216.31K 186.19K 167.48K 148.59K
Weighted Average Shares Outstanding (Diluted)
 250.49K 216.31K 186.19K 167.48K 148.59K
Currency in USD

Quince Therapeutics Earnings and Revenue History